- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01711372
Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices
Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices, Phase 2 Trials
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Current diagnostic aids used in treating ADHD are currently expensive, time intensive, and provide little information about accessory movements in response to a stimulus. One in ten children, ages 5 to 17, has been diagnosed with ADHD.
Tests such as the Conners' Rating Scale require subjective responses from parents and teachers, making coordination difficult. The computerized Conners' Continuous Performance Test (CPT) provides objective data in regards to inattention and impulsive patterns of response. However, it does not provide data regarding accessory movements such as restlessness, hyperactivity, and other inappropriate movements. If the subject taking the exam has a reading disorder, it will impair his or her ability to respond accurately and it will increase response time. The T.O.V.A. is another computer based test used as a diagnostic aid for ADHD, which uses a microswitch to record responses. It does utilize auditory and visual stimuli, which removes the reading level limitation. However, it is unable to measure to measure accessory movements that may be contributing to reaction time and errors of omission and commission.
Because of these limitations, a new company called CogCubed has created a new game based on the Sifteo Cube (http://www.sifteo.com) platform. These new hands-on digitized cubes are unique, motion-sensitive wireless blocks that contain multiple sensors that can interact with one another. CogCubed is providing the data for this study. The game will be played in a 30 minute sessions by subjects ages 6-17. Subjects recruited to play the game will be those with ADHD and those without, matched by gender and age. Those with comorbidities of developmental delay, mental retardation, psychosis, schizophrenia, bipolar disorder and substance use disorders will be excluded, as well as any physiological disability that affects upper limb movement and/or coordination. Informed consent will be obtained from parents and patient prior to administering the game. Parents will fill out a Conner's Brief Rating Scale and a Conner's Brief Rating Scale, Teacher's version will also be supplied to be filled out at school.
The hypothesis is that by analyzing data generated from this new gaming platform named Sifteo for which a game was created, which uses auditory and visual stimuli and distracters, the investigators expect that they will be able to provide a more accurate profile of impulsivity and inattention. The investigators expect that inattention will have more errors of omission and less tilt movements than control and impulsivity will be represented as more commission and greater tilting movements than control. This trial builds on the previous results of our phase 1 trials used to create the predictive algorithms to analyze the data and predict the likelihood of ADHD diagnosis based on patterns of game play behavior.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Saint Louis Park, Minnesota, United States, 55416
- Groves Academy
-
Waconia, Minnesota, United States, 55387
- Egli Assessment
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 6-17, males and females
- Individuals with ADHD
- Individuals without ADHD
- Depressive Disorders
- Anxiety Disorders
- Oppositional Defiant Disorder
- Panic Disorder
- Eating Disorder
Exclusion Criteria:
- Developmental Delay
- IQ below 70
- Low functioning Autism Spectrum Disorders
- Psychosis
- Substance Use Disorders
- Medical comorbidities that involve any motoric disability that affects upper-limb movement and/or strength
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Controls who played Groundskeeper game
Controls played a go/no go task on Sifteo cubes to asses for attentional capabilities.
|
The Groundskeeper game is a go/no go task that captures reaction time and movement using the accelerometers and touch capabilities of the Sifteo cubes.
|
|
Active Comparator: Probands played groundskeeper game
Patients with ADHD played a go/no go task on Sifteo cubes to asses for attentional capabilities
|
The Groundskeeper game is a go/no go task that captures reaction time and movement using the accelerometers and touch capabilities of the Sifteo cubes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Area Under the Receiver Operating Characteristic (ROC) Curve- Groundskeeper Game
Time Frame: 30 minutes
|
ROC charts the false-positive (horizontal axis) and the sensitivity or true-positive rate (vertical axis) of the Groundskeeper game at discriminating child psychiatric patients with and without ADHD.
Determines diagnostic accuracy of Groundskeeper game for ADHD.
For each participant, predicted values were computed from the logistic regression models (correcting for age, sex and medication status).
For each successive point on the logit scale sensitivity and specificity of the logit was computed as a predictor of ADHD diagnosis, by predicting those higher than the cut-point to have ADHD and the others not to have ADHD.
These data were used to draw the ROC curve.
ROC analysis summarized diagnostic efficiency with the area under the curve (AUC) statistic.
The AUC ranges from 0.5 (for a diagnostically useless test) to 1.0 (for a diagnostic test that is a perfect predictor).
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Area Under the Receiver Operating Characteristic (ROC) Curve- Conners Brief Rating Scale Parent Version (Inattention Subscale)
Time Frame: 30 minutes
|
Parent completed the Connors Brief rating Scale Parent Version, with the Inattention subscale extracted for analysis.
Scores for this assessment are converted to percentile scores for each age group with higher scores indicating more likelihood of ADHD.
ROC charts the false-positive rate (horizontal axis) and the sensitivity or true-positive rate (vertical axis) of discriminating child psychiatric patients with and without ADHD.
Determines diagnostic accuracy of Conners Scale for ADHD.
ROC analysis summarizes diagnostic efficiency with the area under the curve (AUC) statistic.
The AUC ranges from 0.5 (for a diagnostically useless test) to 1.0 (for a diagnostic test that is a perfect predictor).
|
30 minutes
|
|
Area Under the Receiver Operating Characteristic (ROC) Curve- Continuous Performance Task (CPT)
Time Frame: 30 minutes
|
CPT measures sustained attention.
Participants were asked to press the space bar whenever any letter except the letter "X: appeared on the computer screen.
Used the percent certainty that the CPT II results were in the clinical range in this analysis.
ROC charts the false-positive rate (horizontal axis) and the sensitivity or true-positive rate (vertical axis) of discriminating child psychiatric patients with and without ADHD.
Determines diagnostic accuracy of Conners scales for ADHD.
ROC analysis summarizes diagnostic efficiency with the Area Under the Curve (AUC) statistic.
The AUC ranges from 0.5 (for a diagnostically useless test) to 1.0 (for a diagnostic test that is a perfect predictor).
|
30 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Monika D Roots, MD, CogCubed, Corp
- Principal Investigator: Jaideep Srivastava, PhD, CogCubed, Corp
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 131209-12
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
Clinical Trials on Groundskeeper game for controls
-
CogCubed, CorpOhio UniversityCompletedAutism Spectrum Disorder | Attention Deficit Hyperactivity Disorder | Asperger's Disorder | Pervasive Developmental DisorderUnited States
-
CogCubed, CorpCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Akili Interactive Labs, Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
University Hospital, GhentRecruitingAlzheimer Disease | Healthy Aging | Mild Cognitive ImpairmentBelgium
-
New York Institute of TechnologyRecruitingHypermobility SyndromeUnited States
-
Milton S. Hershey Medical CenterActive, not recruitingMelanoma | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Liver Cancer | Genito-Urinary CancerUnited States
-
National Taiwan University HospitalEnrolling by invitationPain | Emotions | FearTaiwan
-
University of UtahAmerican Heart Association; National Center for Advancing Translational Sciences...RecruitingCongenital Heart Defect | Serious Games | Congenital Heart Disease in Adolescence | Patient Centered Care | Transition-age Youth | Transition to Adult CareUnited States
-
National Cheng-Kung University HospitalCompletedChronic Kidney Disease | Chronic Renal Failure | Chronic Renal Insufficiency | Advance Care Planning | End of Life Care | Death AnxietyTaiwan
-
Cardiocentro TicinoRecruitingCoronary Artery Disease | Antiplatelet Therapy | Minimally Invasive Coronary Revascularization SurgerySwitzerland